[SYRE] YoY Quarter Result on 30-Sep-2020 [#Q3]

Stock
[SYRE] Spyre Therapeutics, Inc.
Announcement Date
30-Sep-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- 15.80%
YoY- 16.41%
Quarter Report
SYRE's Result
SYRE's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Revenue 0 174 1,399 0 0 0 1,261 -
PBT -40,104 -18,443 -20,281 -18,033 -21,573 -11,917 -7,874 31.15%
Tax 3 -209 26 0 0 0 0 -
NP -40,107 -18,234 -20,307 -18,033 -21,573 -11,917 -7,874 31.15%
Tax Rate - - - - - - - -
Total Cost 40,107 18,408 21,706 18,033 21,573 11,917 9,135 27.94%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
NP Margin 0.00 -10,479.31 -1,451.54 0.00 0.00 0.00 -624.43 -
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
EPS -9.34 -4.84 -7.72 -7.24 -16.40 -13.55 -12.00 -4.08%
EPS Diluted -9.34 -4.84 -7.72 -7.24 -16.40 -13.55 -12.00 -4.08%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.